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Central Venous Occlusions
Stephen P. Maloney, Neil Halin, Mark IafratiTufts Medical Center, Boston,
Mass
Introduction and objectives: Chronically occluded central veins may
result in severe morbidity. Conventional catheter/guidewire techniques
may be successful in crossing and recanalizing most patients, but still fail in
many. We recently utilized a radiofrequency (RF) wire to assist in crossing
difficult central venous occlusions.
Methods: Between May 2008 and May 2010, 22 patients with
symptomatic occlusion or stenosis of the superior vena cava (SVC),
innominate, or subclavian veins were treated at our institution. In four
patients with occlusion, the lesion could not be crossed using conven-
tional techniques. All of these patients had multiple central venous access
procedures. Two pa|tients presented with persistent arm swelling in an
extremity with an arteriovenous fistula. The other two presented with
symptoms of SVC syndrome, one of which had underlying Sjögren
syndrome, hypercoagulability, and a failed atrial-innominate bypass.
These “endovascular failures” were subsequently approached with an RF
generator and Powerwire (Baylis Medical, Montreal, QC, Canada) using
a 0.035-inch guidewire with a heated tip allowing for enhanced passage
through tissue.
Results: Four patients with resistant occlusions were successfully re-
canalized. Total occlusions of both the innominate veins and the SVC were
successfully traversed using the RF wire under fluoroscopic guidance, fol-
lowed by angioplasty and stenting with covered and bare-metal stents. The
average length of vein recanalized was 7.9  3.0 cm, with a mean fluoros-
copy time of 36.7  8.6 minutes. All patients had rapid resolution of
symptoms. One patient required repeat angioplasty at 4 months for in-stent
intimal hyperplasia. However, all stents have remained patent at 3 to 12
months.
Conclusions: The RF wire proved to be a valuable tool in the manage-
ment of patients with refractory chronic central venous occlusions, crossing
lesions that had failed conventional techniques. However, caution is urgedcomprehensive VDUS screening program in neurosurgical patients.Do Relative Value Units (RVUs) Accurately Reflect the Work Done by
Vascular Surgeons?
Neal R. Barshes, Louis L. Nguyen, Michael BelkinBrigham and Women’s
Hospital, Boston, Mass
Introduction and objectives: Work RVUs are intended to reflect
the “time, skill, training, and intensity” of surgeons performing opera-
tions. It is not clear, however, how well work RVUs truly represent such
efforts.
Methods: Data regarding the performance of operative procedures,
including operative time and associated postoperative length of stay, were
obtained from the 2002-2008 NSQIP database. Correlations were made
with work RVUs obtained from the CMS 2009 National Physician Fee
Schedule Relative Value File.
Results:Among the 199 vascular surgery CPTs reviewed (represent-
ing 78,397 operations), there was a moderate correlation between work
RVUs and both median operative time (R2  0.3962, P  .001) and
median postoperative length of stay (R2  0.2353, P  .001). Per unit
time, work RVUs for major amputation were nearly twice that of infrain-
guinal revascularizations. A multivariate regression model identified
“high outliers” (procedures with high RVUs per unit of operative time,
which included TEVAR and open thoracoabdominal aneurysm repair)
and “low outliers” (low RVUs per unit of operative time, which included
reoperative femorotibial bypass). A comparison of the 20 most frequently
performed general surgery procedures (55% of total general surgery
operations) and the 20 most frequently performed vascular surgery
procedures (66% of all vascular operations) demonstrated that the rate of
RVUs generated per median operative time were significantly higher for
general surgery operations than for vascular surgery operations (P 
.0087; see Fig).
Conclusions: Work RVUs are moderately well correlated with op-
erative time and postoperative hospitalization, but work RVUs per unit
time for the most frequently performed vascular surgery operations are
lower than for the most frequently performed general surgery operations.because extraluminal passage is possible, making high-resolution multipla-
nar or 3D spin-imaging technology important.
Periodic review and adjustment of RVUs should be considered to more
accurately reflect the efforts of vascular surgeons.
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Introduction and objectives: Decisions regarding deep venous
thrombosis (DVT) prophylaxis are difficult in neurosurgical patients because
of bleeding risks. Asymptomatic screening protocols with venous duplex
ultrasound (VDUS) imaging may improve outcomes but strain resources.
Because there are little data to guide VDUS surveillance, we investigated aMethods: Medical records of patients admitted to the neurosurgical
service at a university-affiliated hospital from October 2007 through January
2010 were retrospectively reviewed. Demographics, comorbidities, inter-
ventions, and use of DVT prophylaxis were recorded. Asymptomatic pa-
tients underwent weekly VDUS of the lower extremities until ambulatory or
discharged. When DVT was identified, VDUS reported its location and
progression.
Results:A total of 174 consecutive patients were screened according to
the established protocol. They had 312 VDUS studies, 68 (21.8%) of which
were positive in 40 (23%) unique patients; 10 were bilateral, and 2 were
catheter-related. There were no pulmonary emboli. Seventeen (37.7%) were
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Of the isolated calf DVTs, only two progressed to the popliteal vein or
proximal on follow-up. No examined risk factor predicted DVT. Mechanical
prophylaxis was uniformly used, but chemical prophylaxis varied based on
surgeon preference. DVT developed in 19.3% (28 of 145) of patients
receiving prophylactic medication (unfractionated heparin or low-molecu-
lar-weight heparin) and in 41.4% (12 of 29) receiving no medication (P 
.001).
Conclusions: Despite application of mechanical and chemical DVT
prophylaxis, we found a 23% incidence of DVT in hospitalized, nonambu-
latory, neurosurgical patients. No patients with isolated calf DVT had an
embolic complication, and only 11.7% progressed proximally. Although
chemical prophylaxis reduced DVT risk, no factor was sufficiently predictive
to exclude patients from screening. These data substantiate the importancecells were serum starved for 24 hours to synchronize them to the G0 phase.
HCASMCs were then stimulated into the cell cycle and harvested for totalContinuous Inhibition of Poly-ADP Ribose Polymerase Improves
Functional Recovery and Modulates Skeletal Muscle Regeneration
Following Hind Limb Ischemia and Reperfusion
Mounir J. Haurani, Hassan Albadawi, Rabih Houbballah, Bao-Ngoc
Nguyen, Hyung-Jin Yoo, Glen M. LaMuraglia, Michael T. WatkinsMassa-
chusetts General Hospital, Boston, Mass
Introduction and objectives: Poly (ADP)-ribose polymerase (PARP)
inhibition during the acute phase of limb ischemia/reperfusion injury (IR)
has been shown to be protective; however, elevated levels of PARP activity
persists during the chronic phase of reperfusion. The primary goal of these
experiments was to determine whether ongoing post hoc PARP inhibition
potentiated muscle regeneration and functional recovery after IR.
Methods: C57BL6/J mice were subjected to 1.5 hours of unilateral
hind limb ischemia, followed by 2 weeks of reperfusion. During ischemia,of VDUS screening and support revising our protocol to evaluate femoral
and popliteal veins only.
mice were treated with a PARP inhibitor PJ34 (PJ, n 12) by implantation
of a continuous slow-release pellet (10 mg/kg/d for 14 days), or placebo
Table. Outcomes of PARP inhibition
Variable PJ34 Control P
Ambulation score (1  normal, 4  dragging) 1.7 2.8 .001
Peak force muscle contracture, grams 68.1 62.1 .03
PAR expression
Densitometry value 14,288  1276 26,839  5830 .022
Percent immature fibers 8.32  4.70 77.5  8.2 .001
ATP
Tissue level, nmol/mg 5.93  0.27 3.73  0.50 .001
Myogenin
Densitometry value 45,285  6,340 83,531  22,507 .051
Perfusion ratio (injured/noninjured limb) 0.959  0.048 0.921  0.062 .636pellet (control, n  12). Hind limb function was analyzed with ambula-
tion scoring scale and muscle contractility using direct muscle stimula-
tion. Muscle regeneration and PARP activity were assessed by immuno-
blotting for myogenin, a transcription factor associated with myofibers
differentiation, and poly ADP-ribose (PAR). ATP levels were measured
with chemiluminescence. Immature muscle fibers were counted micro-
scopically. Hind limb perfusion ratios were measured by laser-Doppler
imaging.
Results: Inhibition of PARP was confirmed by decreased PAR expres-
sion in PJ mice (see Table). Ambulation scores and muscle contractility were
improved in PJ mice. This improved functional status correlated with a
higher number of mature muscle fibers and preservation of ATP. Myogenin
expression was decreased in PJ mice, but was not significant. These changes
were not due to differences in perfusion based on laser-Doppler imaging
ratios.
Conclusions: Continuous PARP inhibition significantly improves
hind limb function after IR. This improved function is associated with
increased numbers of mature fibers and improved levels of high-energy
phosphate in the muscle. PJ34 may prove to be a pharmacologic treat-
ment useful in ameliorating the effects of reperfusion injury after isch-
emia insult.
A Possible Role for MAP Kinases and MARCKS Interaction in the
Development of Intimal Hyperplasia and Graft Failure
Lindsey M. Korepta, Michelle C. Martin, Patrick Guthrie, Leena Pradhan,
Christiane J. Ferran, Frank W. LoGerfoBeth Israel Deaconess Medical
Center, Boston, Mass
Introduction and objectives: The myristoylated alanine-rich C-kinase
substrate (MARCKS), a major protein kinase C substrate, is upregulated in
intimal hyperplasia (IH), yet its signaling pathway remains undetermined.
Through inhibition of vascular smooth muscle cell (VSMC) migration and
proliferation, p27kip1, a cyclin-dependent kinase inhibitor, regulates IH. We
have previously demonstrated MARCKS siRNA-mediated knockdown de-
creases VSMC migration and proliferation and increases p27kip1 expression.
The MAP kinases SAP/JNK, p38, and ERK1/2 are important regulators of
the cell cycle and interact with p27kip1. The goal of the present study was to
monitor the protein expression of p38, ERK1/2, and SAP-JNK in the
setting of MARCKS knockdown.
Methods: Human coronary artery smooth muscle cells (HCASMC)
were transfected with 50 nm control, or MARCKS siRNA, or vehicle. Theprotein extraction along different points of the cell cycle (0 and 30 minutes,
18 and 24 hours). Western blot analysis was performed to monitor the
protein expression of MARCKS, p27kip1, p38, ERK1/2, and SAP/JNK.
Results: All of the following results are presented as percent change in
protein expression in MARCKS siRNA-treated HCASMCs compared with
control siRNA-treated HCASMCs. MARCKS siRNA treatment resulted in
(1) 40% to 75% decrease in MARCKS expression at all different time points,
(2) a 30% increase in p27kip1 at all different time points, (3) no change in p38
expression at 0 and 30 minutes and a 25% increase at later time points, (4) no
change in SAP-JNK expression at 0 and 30 minutes and a 30% to 78%
increase at later time points, (5) no change in ERK1/2 expression at all
different time points.
Conclusions: The results of this study shed light on a possible IH
signaling pathway mediated by MARCKS through p27kip1, p38, and SAP-
JNK MAP kinase regulation.
A Novel In Vitro Flow Model That Recapitulates Alterations of Vessel
Identity During Vein Graft Adaptation In Vivo
Lynn Model, Akihito Muto, Clay Quint, Yuka Kondo, Amanda Feigel,
Kenneth Ziegler, Sammy Egbalieh, Laura Niklason, Alan DardikYale Uni-
versity, New Haven, Conn
Introduction and objectives: Conventional in vitro flow models of
vein graft adaptation have not previously characterized the vessels according
to their markers of specificity. In particular, it is not known whether in vitro
models of vein graft adaptation mimic physiologically reduced expression of
the venous determinant ephrin-B4 or whether they stimulate expression of
the arterial determinant ephrin-B2.
Methods: Saphenous vein remnants were taken from the operating
room and immediately placed in a flow circuit. Medium was circulated at 20
dyne/cm2 for 24 hours, and then specimens were analyzed with H&E, von
Giessen, and TUNEL staining. Protein was analyzed using Western blot-
ting, and was RNA analyzed using qPCR.
Results: After 24 hours of arterial flow in vitro, saphenous veins were
viable, with no detectable induction of either activated caspase-3 or PARP
cleavage (n  6); TUNEL staining showed no increase over baseline.
Endothelial cells were identified on the luminal surface, and PECAM was
present both initially and after 24 hours of flow. Ephrin-B4 expression was
diminished (n  6, P  .04), and there was no induction of ephrin-B2
expression (n 6, P .001). Expression of osteopontin (n 7, P .001),
a marker of vein graft adaptation, was increased.
Conclusions: This novel in vitro flow model preserves human saphe-
nous vein viability for at least 24 hours, including vessel endothelium. When
exposed to the bioreactor environment, markers of venous and arterial
